Lisa Marie Harding

Lisa Marie Harding, MD, is an Assistant Clinical Professor in the Department of Psychiatry at Yale School of Medicine. Board Certified in Psychiatry & Neurology (2020), she specializes in interventional psychiatry with over 4,000 procedures in Electroconvulsive Therapy (ECT), IV Ketamine, Spravato, and Transcranial Magnetic Stimulation (TMS). Currently active in the American Psychiatric Association and American Academy of Psychiatry and the Law, she focuses on treating complex psychiatric cases and improving mental health equity.

• Completed Psychiatry residency at Yale School of Medicine
• Chief of Interventional Psychiatry during residency
• Specializes in pharmacologically complex cases and psychotherapy

Her research explores treatment patterns for resistant depression, access to ketamine therapies, and social determinants affecting care initiation. Recent publications examine geographic barriers to esketamine treatment and cost implications of treatment-resistant depression management.

Scientific Awards:

• Irma Bland Award for Excellence in Teaching Residents (2023)
• American Psychiatric Foundation Ambassador
• Rappeport Fellow, American Academy of Psychiatry and the Law

Dr. Harding maintains a clinical focus on optimizing medication regimens while advocating for equitable mental healthcare access through policy development and community engagement initiatives.